<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="9" family="GillSans,BoldItalic" color="#000000"/>
	<fontspec id="font6" size="10" family="GillSans,Bold" color="#ffffff"/>
	<fontspec id="font7" size="10" family="GillSans" color="#ffffff"/>
	<fontspec id="font8" size="10" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font9" size="10" family="GillSans,Italic" color="#000000"/>
	<fontspec id="font10" size="10" family="GillSans" color="#000000"/>
	<fontspec id="font11" size="7" family="Helvetica" color="#000000"/>
	<fontspec id="font12" size="8" family="KEAFMQ+Helvetica,Bold" color="#000000"/>
	<fontspec id="font13" size="5" family="Helvetica" color="#000000"/>
	<fontspec id="font14" size="8" family="KEAFMQ+Helvetica,Bold" color="#000000"/>
	<fontspec id="font15" size="8" family="Helvetica" color="#000000"/>
	<fontspec id="font16" size="10" family="GillSans,Italic" color="#ffffff"/>
	<fontspec id="font17" size="7" family="WQXUUO+Helvetica,Bold" color="#000000"/>
	<fontspec id="font18" size="6" family="XSTBFC+Helvetica" color="#000000"/>
	<fontspec id="font19" size="10" family="WQXUUO+Helvetica,Bold" color="#000000"/>
<text top="41" left="55" width="144" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title">Journal of Carcinogenesis 2006, 5 :4<i>Journal of Carcinogenesis</i></text>
<text top="41" left="376" width="178" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="1" tag_type="text">http://www.carcinogenesis.com/content/5/1/4</text>
<text top="756" left="508" width="46" height="10" font="font1" id="p1_t3" reading_order_no="116" segment_no="14" tag_type="text">Page 7 of 9<b>5</b></text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t4" reading_order_no="117" segment_no="15" tag_type="text">(page number not for citation purposes)</text>
<text top="380" left="55" width="241" height="9" font="font4" id="p1_t5" reading_order_no="38" segment_no="6" tag_type="text">Positive tumors mostly showed more than 75% of stained</text>
<text top="392" left="55" width="241" height="9" font="font4" id="p1_t6" reading_order_no="39" segment_no="6" tag_type="text">cells (68/91; 74.7%). Proportions of PTTG-1 positive</text>
<text top="404" left="55" width="241" height="9" font="font4" id="p1_t7" reading_order_no="40" segment_no="6" tag_type="text">tumor cells between 1% and 50%, between 51% and 75%<i>(page number not for citation purposes)</i></text>
<text top="416" left="55" width="241" height="9" font="font4" id="p1_t8" reading_order_no="41" segment_no="6" tag_type="text">were found in 6 (6.6%) and 15 (16.5%) of all tumors,</text>
<text top="427" left="55" width="241" height="9" font="font4" id="p1_t9" reading_order_no="42" segment_no="6" tag_type="text">respectively, only 2 (2.2%) cases were PTTG-1 negative</text>
<text top="439" left="55" width="44" height="9" font="font4" id="p1_t10" reading_order_no="43" segment_no="6" tag_type="text">(Figure 4).</text>
<text top="463" left="55" width="241" height="9" font="font5" id="p1_t11" reading_order_no="44" segment_no="7" tag_type="title">Prognostic value of PTTG-1 in patients with NSCLC using</text>
<text top="475" left="55" width="120" height="9" font="font5" id="p1_t12" reading_order_no="45" segment_no="7" tag_type="title">Kaplan-Meier survival curves</text>
<text top="486" left="55" width="241" height="9" font="font4" id="p1_t13" reading_order_no="46" segment_no="8" tag_type="text">Median and mean survival rates for all 91 patients with<a href="">igure 4</a>).</text>
<text top="498" left="55" width="241" height="9" font="font4" id="p1_t14" reading_order_no="47" segment_no="8" tag_type="text">NSCLC were found to be 401 ± 41 days and 325 ± 56 days.<i><b>Prognostic value of PTTG-1 in patients with NSCLC using </b></i></text>
<text top="510" left="55" width="241" height="9" font="font4" id="p1_t15" reading_order_no="48" segment_no="8" tag_type="text">Patients with NSCLC had one year and five year survival<i><b>Kaplan-Meier survival curves</b></i></text>
<text top="521" left="55" width="160" height="9" font="font4" id="p1_t16" reading_order_no="49" segment_no="8" tag_type="text">rates of 46.6% and 1.2%, respectively.</text>
<text top="545" left="55" width="241" height="9" font="font4" id="p1_t17" reading_order_no="50" segment_no="10" tag_type="text">No significant difference between median and mean sur-</text>
<text top="557" left="55" width="241" height="9" font="font4" id="p1_t18" reading_order_no="51" segment_no="10" tag_type="text">vival was observed for tumors from patients with no or</text>
<text top="568" left="55" width="241" height="9" font="font4" id="p1_t19" reading_order_no="52" segment_no="10" tag_type="text">low PTTG-1 expression (p = 0.3063). Consequently, neg-</text>
<text top="580" left="55" width="241" height="9" font="font4" id="p1_t20" reading_order_no="53" segment_no="10" tag_type="text">ative and low stained cases were grouped together. As a</text>
<text top="592" left="55" width="241" height="9" font="font4" id="p1_t21" reading_order_no="54" segment_no="10" tag_type="text">result PTTG-1 expression was negatively correlated with</text>
<text top="604" left="55" width="241" height="9" font="font4" id="p1_t22" reading_order_no="55" segment_no="10" tag_type="text">survival. Patients with strong PTTG-1 expression had an</text>
<text top="615" left="55" width="241" height="9" font="font4" id="p1_t23" reading_order_no="56" segment_no="10" tag_type="text">unfavourable prognosis showing a mean survival of 306 ±</text>
<text top="627" left="55" width="241" height="9" font="font4" id="p1_t24" reading_order_no="57" segment_no="10" tag_type="text">58 days compared with patients with PTTG-1 low or</text>
<text top="639" left="55" width="241" height="9" font="font4" id="p1_t25" reading_order_no="58" segment_no="10" tag_type="text">PTTG-1 negative stainings with a mean survival of 463 ±</text>
<text top="651" left="55" width="136" height="9" font="font4" id="p1_t26" reading_order_no="59" segment_no="10" tag_type="text">55 days (p = 0.0386; Figure 5A).</text>
<text top="674" left="55" width="241" height="9" font="font4" id="p1_t27" reading_order_no="60" segment_no="12" tag_type="text">In order to exclude a possible bias due to different thera-</text>
<text top="686" left="55" width="241" height="9" font="font4" id="p1_t28" reading_order_no="61" segment_no="12" tag_type="text">pies, surgically resected patients, who had a significant</text>
<text top="698" left="55" width="241" height="9" font="font4" id="p1_t29" reading_order_no="62" segment_no="12" tag_type="text">better overall survival than unresected patients (p =<a href="">6; Figure 5A).</a></text>
<text top="709" left="55" width="241" height="9" font="font4" id="p1_t30" reading_order_no="63" segment_no="12" tag_type="text">0.0001), were removed from the analysis. Looking at the</text>
<text top="721" left="55" width="241" height="9" font="font4" id="p1_t31" reading_order_no="64" segment_no="12" tag_type="text">subgroup of patients in stage IIIB and IV (n = 76) receiving</text>
<text top="698" left="313" width="241" height="9" font="font4" id="p1_t32" reading_order_no="113" segment_no="13" tag_type="text">palliative chemotherapy, a significant difference on sur-</text>
<text top="709" left="313" width="241" height="9" font="font4" id="p1_t33" reading_order_no="114" segment_no="13" tag_type="text">vival (p = 0.0229) with regard to PTTG-1 expression was</text>
<text top="721" left="313" width="115" height="9" font="font4" id="p1_t34" reading_order_no="115" segment_no="13" tag_type="text">observed again (Figure 5B).</text>
<text top="537" left="313" width="238" height="9" font="font6" id="p1_t35" reading_order_no="99" segment_no="9" tag_type="title">5A and 5B Association of PTTG-1 expression and survival</text>
<text top="537" left="313" width="72" height="9" font="font7" id="p1_t36" reading_order_no="100" segment_no="9" tag_type="title">in NSCLC tumors</text>
<text top="537" left="313" width="37" height="9" font="font8" id="p1_t37" reading_order_no="98" segment_no="9" tag_type="title">Figure 5<a href="">e 5B).</a></text>
<text top="548" left="313" width="228" height="9" font="font8" id="p1_t38" reading_order_no="101" segment_no="11" tag_type="text">5A and 5B Association of PTTG-1 expression and survival in<b>5A and 5B </b></text>
<text top="559" left="313" width="219" height="9" font="font9" id="p1_t39" reading_order_no="102" segment_no="11" tag_type="text">NSCLC tumors . (A): statistical difference in survival time</text>
<text top="570" left="313" width="234" height="9" font="font10" id="p1_t40" reading_order_no="103" segment_no="11" tag_type="text">between patients with NSCLC (n = 91) of no/low PTTG-1</text>
<text top="580" left="313" width="239" height="9" font="font10" id="p1_t41" reading_order_no="104" segment_no="11" tag_type="text">expression (black line) and strong PTTG-1 expression (grey<b>Figure 5</b></text>
<text top="591" left="313" width="241" height="9" font="font10" id="p1_t42" reading_order_no="105" segment_no="11" tag_type="text">line) was seen. Patients with strong PTTG-1 expression had a<b>5A and 5B </b></text>
<text top="602" left="313" width="237" height="9" font="font10" id="p1_t43" reading_order_no="106" segment_no="11" tag_type="text">significant (p = 0.0386) shorter survival time. (B): looking at<i>Association of PTTG-1 expression and survival in </i></text>
<text top="613" left="313" width="213" height="9" font="font10" id="p1_t44" reading_order_no="107" segment_no="11" tag_type="text">PTTG-1 expression for the subgroup of patients with<i>NSCLC tumors</i></text>
<text top="623" left="313" width="241" height="9" font="font10" id="p1_t45" reading_order_no="108" segment_no="11" tag_type="text">advanced NSCLC receiving palliative chemotherapy (n = 76),</text>
<text top="634" left="313" width="237" height="9" font="font10" id="p1_t46" reading_order_no="109" segment_no="11" tag_type="text">a statistically significant difference on survival time between</text>
<text top="645" left="313" width="232" height="9" font="font10" id="p1_t47" reading_order_no="110" segment_no="11" tag_type="text">PTTG-1 no/low expressing group (black line) and PTTG-1</text>
<text top="656" left="313" width="216" height="9" font="font10" id="p1_t48" reading_order_no="111" segment_no="11" tag_type="text">strong expressing group (grey line) was observed (p =</text>
<text top="666" left="313" width="32" height="9" font="font10" id="p1_t49" reading_order_no="112" segment_no="11" tag_type="text">0.0229).</text>
<text top="286" left="348" width="4" height="6" font="font11" id="p1_t50" reading_order_no="75" segment_no="2" tag_type="figure">0</text>
<text top="286" left="436" width="11" height="6" font="font11" id="p1_t51" reading_order_no="76" segment_no="2" tag_type="figure">500</text>
<text top="286" left="527" width="16" height="6" font="font11" id="p1_t52" reading_order_no="77" segment_no="2" tag_type="figure">1000</text>
<text top="295" left="413" width="58" height="8" font="font12" id="p1_t53" reading_order_no="79" segment_no="2" tag_type="figure">Survival in days</text>
<text top="277" left="337" width="7" height="5" font="font13" id="p1_t54" reading_order_no="74" segment_no="2" tag_type="figure">0,0</text>
<text top="242" left="337" width="7" height="5" font="font13" id="p1_t55" reading_order_no="73" segment_no="2" tag_type="figure">0,2</text>
<text top="207" left="337" width="7" height="5" font="font13" id="p1_t56" reading_order_no="72" segment_no="2" tag_type="figure">0,4</text>
<text top="172" left="337" width="7" height="5" font="font13" id="p1_t57" reading_order_no="71" segment_no="2" tag_type="figure">0,6</text>
<text top="137" left="337" width="7" height="5" font="font13" id="p1_t58" reading_order_no="70" segment_no="2" tag_type="figure">0,8</text>
<text top="103" left="338" width="7" height="5" font="font13" id="p1_t59" reading_order_no="69" segment_no="2" tag_type="figure">1,0<b>Survival in days</b></text>
<text top="189" left="334" width="0" height="40" font="font14" id="p1_t60" reading_order_no="68" segment_no="2" tag_type="figure">ve ti la u m u C</text>
<text top="178" left="334" width="0" height="8" font="font14" id="p1_t61" reading_order_no="67" segment_no="2" tag_type="figure">su</text>
<text top="169" left="334" width="0" height="8" font="font14" id="p1_t62" reading_order_no="66" segment_no="2" tag_type="figure">rv</text>
<text top="156" left="334" width="0" height="14" font="font14" id="p1_t63" reading_order_no="65" segment_no="2" tag_type="figure">al iv</text>
<text top="176" left="454" width="32" height="7" font="font15" id="p1_t64" reading_order_no="78" segment_no="2" tag_type="figure">p=0.0386</text>
<text top="498" left="349" width="4" height="6" font="font11" id="p1_t65" reading_order_no="93" segment_no="2" tag_type="figure">0</text>
<text top="498" left="438" width="12" height="6" font="font11" id="p1_t66" reading_order_no="94" segment_no="2" tag_type="figure">500<b>C</b></text>
<text top="498" left="529" width="16" height="6" font="font11" id="p1_t67" reading_order_no="95" segment_no="2" tag_type="figure">1000<b>u</b></text>
<text top="507" left="414" width="59" height="8" font="font12" id="p1_t68" reading_order_no="97" segment_no="2" tag_type="figure">Survival in days<b>m</b></text>
<text top="488" left="338" width="7" height="5" font="font13" id="p1_t69" reading_order_no="92" segment_no="2" tag_type="figure">0,0<b>u</b></text>
<text top="452" left="338" width="7" height="5" font="font13" id="p1_t70" reading_order_no="91" segment_no="2" tag_type="figure">0,2<b>la</b></text>
<text top="416" left="338" width="7" height="5" font="font13" id="p1_t71" reading_order_no="90" segment_no="2" tag_type="figure">0,4<b>ti</b></text>
<text top="379" left="338" width="7" height="5" font="font13" id="p1_t72" reading_order_no="89" segment_no="2" tag_type="figure">0,6<b>ve</b></text>
<text top="343" left="338" width="7" height="5" font="font13" id="p1_t73" reading_order_no="88" segment_no="2" tag_type="figure">0,8<b>su</b></text>
<text top="307" left="339" width="7" height="5" font="font13" id="p1_t74" reading_order_no="87" segment_no="2" tag_type="figure">1,0<b>rv</b></text>
<text top="429" left="335" width="0" height="9" font="font14" id="p1_t75" reading_order_no="86" segment_no="2" tag_type="figure">Cu<b>iv</b></text>
<text top="419" left="335" width="0" height="9" font="font14" id="p1_t76" reading_order_no="85" segment_no="2" tag_type="figure">m<b>al</b></text>
<text top="408" left="335" width="0" height="13" font="font14" id="p1_t77" reading_order_no="84" segment_no="2" tag_type="figure">la u</text>
<text top="396" left="335" width="0" height="14" font="font14" id="p1_t78" reading_order_no="83" segment_no="2" tag_type="figure">ve ti</text>
<text top="386" left="335" width="0" height="9" font="font14" id="p1_t79" reading_order_no="82" segment_no="2" tag_type="figure">su</text>
<text top="377" left="335" width="0" height="9" font="font14" id="p1_t80" reading_order_no="81" segment_no="2" tag_type="figure">rv</text>
<text top="359" left="335" width="0" height="20" font="font14" id="p1_t81" reading_order_no="80" segment_no="2" tag_type="figure">l a iv<b>Survival in days</b></text>
<text top="391" left="452" width="32" height="7" font="font15" id="p1_t82" reading_order_no="96" segment_no="2" tag_type="figure">p=0.0229</text>
<text top="282" left="55" width="223" height="9" font="font7" id="p1_t83" reading_order_no="32" segment_no="4" tag_type="title">Proportion of PTTG-1 positive tumor cells and PTTG-1</text>
<text top="282" left="55" width="240" height="9" font="font7" id="p1_t84" reading_order_no="30" segment_no="4" tag_type="title">staining intensities of NSCLC (N = 91); white bar represents</text>
<text top="282" left="55" width="229" height="9" font="font7" id="p1_t85" reading_order_no="29" segment_no="4" tag_type="title">PTTG-1 negative cases; light grey and black bars represent</text>
<text top="282" left="55" width="229" height="9" font="font7" id="p1_t86" reading_order_no="31" segment_no="4" tag_type="title">PTTG-1 low and strongly stained NSCLC tumors, respec-</text>
<text top="282" left="55" width="21" height="9" font="font7" id="p1_t87" reading_order_no="27" segment_no="4" tag_type="title">tively</text>
<text top="282" left="55" width="37" height="9" font="font8" id="p1_t88" reading_order_no="28" segment_no="4" tag_type="title">Figure 4<b>Cu</b></text>
<text top="293" left="55" width="223" height="9" font="font10" id="p1_t89" reading_order_no="33" segment_no="5" tag_type="text">Proportion of PTTG-1 positive tumor cells and PTTG-1<b>m</b></text>
<text top="304" left="55" width="240" height="9" font="font10" id="p1_t90" reading_order_no="34" segment_no="5" tag_type="text">staining intensities of NSCLC (N = 91); white bar represents<b>u</b></text>
<text top="315" left="55" width="229" height="9" font="font10" id="p1_t91" reading_order_no="35" segment_no="5" tag_type="text">PTTG-1 negative cases; light grey and black bars represent<b>la</b></text>
<text top="325" left="55" width="229" height="9" font="font10" id="p1_t92" reading_order_no="36" segment_no="5" tag_type="text">PTTG-1 low and strongly stained NSCLC tumors, respec-<b>ti</b></text>
<text top="336" left="55" width="23" height="9" font="font10" id="p1_t93" reading_order_no="37" segment_no="5" tag_type="text">tively.<b>ve</b></text>
<text top="252" left="115" width="30" height="8" font="font17" id="p1_t94" reading_order_no="23" segment_no="3" tag_type="figure">Negative<b>su</b></text>
<text top="252" left="160" width="21" height="8" font="font17" id="p1_t95" reading_order_no="24" segment_no="3" tag_type="figure">1-50%<b>rv</b></text>
<text top="252" left="195" width="30" height="8" font="font17" id="p1_t96" reading_order_no="25" segment_no="3" tag_type="figure">&gt;50-75%<b>iv</b></text>
<text top="252" left="240" width="19" height="8" font="font17" id="p1_t97" reading_order_no="26" segment_no="3" tag_type="figure">&gt;75%<b>a</b></text>
<text top="242" left="97" width="3" height="8" font="font18" id="p1_t98" reading_order_no="22" segment_no="3" tag_type="figure">0<b>l</b></text>
<text top="224" left="94" width="6" height="8" font="font18" id="p1_t99" reading_order_no="21" segment_no="3" tag_type="figure">10</text>
<text top="206" left="93" width="7" height="8" font="font18" id="p1_t100" reading_order_no="20" segment_no="3" tag_type="figure">20</text>
<text top="187" left="93" width="7" height="8" font="font18" id="p1_t101" reading_order_no="19" segment_no="3" tag_type="figure">30</text>
<text top="169" left="93" width="7" height="8" font="font18" id="p1_t102" reading_order_no="18" segment_no="3" tag_type="figure">40<i>white bar </i></text>
<text top="150" left="93" width="7" height="8" font="font18" id="p1_t103" reading_order_no="17" segment_no="3" tag_type="figure">50</text>
<text top="132" left="93" width="7" height="8" font="font18" id="p1_t104" reading_order_no="16" segment_no="3" tag_type="figure">60</text>
<text top="114" left="93" width="7" height="8" font="font18" id="p1_t105" reading_order_no="15" segment_no="3" tag_type="figure">70<i>light grey </i></text>
<text top="234" left="78" width="0" height="12" font="font19" id="p1_t106" reading_order_no="11" segment_no="3" tag_type="figure">N</text>
<text top="220" left="78" width="0" height="18" font="font19" id="p1_t107" reading_order_no="10" segment_no="3" tag_type="figure">m u<i>black bars </i></text>
<text top="205" left="78" width="0" height="18" font="font19" id="p1_t108" reading_order_no="9" segment_no="3" tag_type="figure">er b</text>
<text top="180" left="78" width="0" height="24" font="font19" id="p1_t109" reading_order_no="8" segment_no="3" tag_type="figure">ab f o</text>
<text top="168" left="78" width="0" height="12" font="font19" id="p1_t110" reading_order_no="7" segment_no="3" tag_type="figure">so</text>
<text top="156" left="78" width="0" height="12" font="font19" id="p1_t111" reading_order_no="6" segment_no="3" tag_type="figure">lu<b>Figure 4</b></text>
<text top="147" left="78" width="0" height="12" font="font19" id="p1_t112" reading_order_no="5" segment_no="3" tag_type="figure">te</text>
<text top="135" left="78" width="0" height="12" font="font19" id="p1_t113" reading_order_no="4" segment_no="3" tag_type="figure">ca</text>
<text top="124" left="78" width="0" height="12" font="font19" id="p1_t114" reading_order_no="3" segment_no="3" tag_type="figure">se<i>white bar </i></text>
<text top="113" left="78" width="0" height="12" font="font19" id="p1_t115" reading_order_no="2" segment_no="3" tag_type="figure">s</text>
<text top="184" left="89" width="0" height="12" font="font19" id="p1_t116" reading_order_no="14" segment_no="3" tag_type="figure">(N</text>
<text top="173" left="89" width="0" height="12" font="font19" id="p1_t117" reading_order_no="13" segment_no="3" tag_type="figure">=9<i>light grey </i></text>
<text top="162" left="89" width="0" height="12" font="font19" id="p1_t118" reading_order_no="12" segment_no="3" tag_type="figure">1)</text>
</page>
</pdf2xml>
